TRIB - Trinity Biotech plc

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue99,611100,195104,872
Cost of Revenue56,12753,68355,496
Gross Profit43,48446,51249,376
Operating Expenses
Research Development5,0405,0694,291
Selling General and Administrative30,12727,93729,647
Non Recurring48,16548,16548,165
Total Operating Expenses---
Operating Income or Loss-39,84813,50615,438
Income from Continuing Operations
Total Other Income/Expenses Net3,14713,49197
Earnings Before Interest and Taxes-36,70126,99715,535
Interest Expense5,4394,054132
Income Before Tax-42,14022,94315,403
Income Tax Expense-3,557756479
Minority Interest---
Net Income From Continuing Ops-38,58322,18714,924
Non-recurring Events
Discontinued Operations-62,042-3912,290
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-100,62521,79617,214
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-100,62521,79617,214